Released May 4, 2023, after the close
10-Q filed May 4, 2023, 34 days after period end · 0001437749-23-012566
Q1 2023 · 10-Q
Revenue$269.56M$269.56M −3.4% vs Q1 2022+1.9% vs Q4 2022
Net Income$11.72M$11.72M −23.5% vs Q1 2022+84.5% vs Q4 2022
EPS Diluted$0.76$0.76 −23.2% vs Q1 2022no prior Q4 2022 on file
Operating Income$10,012,000−29.6%
Operating Cash Flow$13,857,000N/M
Free Cash Flowderived$7,217,000N/M
Margins · derived
Operating margin3.7%−1.4 pt vs Q1 2022
Net margin4.3%−1.1 pt vs Q1 2022
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $269.56M | $278.98M | $250.97M | $256.12M |
| Net Income | $11.72M | $15.32M | $21.27M | -$26.85M |
| EPS Diluted | $0.76 | $0.99 | $1.38 | -$1.76 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Healthcare Corp · CIK 1047335 · Engraved from SEC EDGAR